SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (2584)4/29/1997 7:41:00 PM
From: Harry Stover   of 4342
 
Hello,

I cut this from Paracelsian's home page, I don't know if it is anything significant:

FORMER NATIONAL INSTITUTES OF HEALTH AND MERCK SCIENTIST
JOINS THE COMPANY IMMEDIATELY

ITHACA, NY, March 26, 1997-Paracelsian Inc. (NASDAQ: PRLN) announced that
Alfred Alberts has been engaged as a consultant by the Company effective today.
Mr. Alberts's experience includes Vice President, Biochemistry and Natural Products
Discovery at Merck & Co. Inc., where he was involved in the discovery of natural
product leads for a broad range of human and animal related targets. Mr. Alberts'
experience in Natural Products Discovery will enable him to provide guidance to the
Company as it proceeds with the approaches initiated by Dr. John Babish.

Mr. Alberts has had a distinguished career having worked in the National Institutes
of Health, the Department of Biological Chemistry at Washington University School
of Medicine, St. Louis, and subsequently from 1975 to 1995 at Merck & Co. Inc,
where he also directed programs in atherosclerosis, diabetes and obesity. He was
responsible for the discovery and development of lovastatin (Mevacor) and
simvastatin (Zocor).

Keith Rhodes, Chairman of the Board of Paracelsian, Inc., said, "Paracelsian is
honored that such a distinguished scientist as Mr. Alberts is willing to contribute to
the Company's ongoing scientific effort. His experience in discovering and
developing two world leading drugs will be invaluable to the Company, and his
expertise in Natural Products Discovery should further strengthen the Company's
existing programs."

Mr. Alberts is a member of the boards of directors of Inflazyme Pharmaceuticals Ltd.,
and of Tripos, Inc., and also has served as a consultant to many pharmaceutical and
biotechnology companies.

Paracelsian is a biotechnology company engaged in the discovery of useful products
from herbal sources. Its discoveries are accomplished by applying the Company's
proprietary screening technology, based in signal transduction, to its library of
extracts used in Traditional Chinese Medicine.

Thanks,
Harry pidipady@juno.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext